86
Views
4
CrossRef citations to date
0
Altmetric
Original article

Elevated caspase 3 activity and cytosolic cytochrome c in NT2 cybrids containing amyotrophic lateral sclerosis subject mtDNA

&
Pages 839-849 | Received 06 Mar 2014, Accepted 17 Jul 2015, Published online: 02 Oct 2015

References

  • Shrivastava M, Vivekanandhan S, Pati U, et al. Mitochondrial perturbance and execution of apoptosis in platelet mitochondria of patients with amyotrophic lateral sclerosis. Int J Neurosci 2011;121(3):149–58.
  • Heath PR, Kirby J, Shaw PJ. Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics. Front Cell Neurosci 2013;7:259. doi:10.3389/ fncel.2013.00259
  • Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med. 2003;348(14):1365–75.
  • Troost D, Aten J, Morsink F, de Jong JM. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons: Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol 1995;21:498–504.
  • Borthwick GM, Johnson MA, Ince PG, et al. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol 1999;46(5):787–90.
  • Beal MF. Mitochondria, free radicals, and neurodegeneration. Curr Opin Neurobiol 1996;6(5):661–6.
  • Swerdlow RH, Parks JK, Cassarino DS, et al. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol 1998;153:135–42.
  • Barber SC, Mead RJ, Shaw PJ. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 2006;1762(11–12):1051–67.
  • Bacman SR, Bradley WG, Moraes CT. Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target? Mol Neurobiol 2006; 33(2):113–31.
  • Beal MF. Mitochondria and the pathogenesis of ALS. Brain 2000;123(7):1291–2.
  • Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 2010;48(5):629–41.
  • Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479–89.
  • Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770–6.
  • Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001;15:2922–33.
  • Swerdlow RH, Parks JK, Cassarino DS, et al. Cybridsin Alzheimer's disease: a cellular model of the disease? Neurology 1997;49:918–25.
  • Swerdlow RH. Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies. J Neurosci Res 2007;85:3416–28.
  • Shrivastava M, Das TK, Behari M, et al. Ultrastructural variations in platelets and platelet mitochondria: a novel feature in amyotrophic lateral sclerosis. Ultrastruct Pathol 2011;35(2):52–9.
  • Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion 2003;43(4):526–35.
  • Ghosh SS, Swerdlow RH, Miller SW, et al. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Ann New York Acad Sci 1999;893:176–91.
  • Esteves AR, Lu J, Rodova M, et al. Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer. J Neurochem 2010;113(3):674–82.
  • Gan X, Huang S, Wu L, et al. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell. Biochim Biophys Acta 2014;1842(2):220–31.
  • Ferreira IL, Nascimento MV, Ribeiro M, et al. Mitochondrial-dependent apoptosis in Huntington's disease human cybrids. Exp Neurol 2010;222(2):243–55.
  • Behari M, Shrivastava M. Role of platelets in neurodegenerative diseases: a universal pathophysiology. Int J Neurosci 2013;123(5):287–99.
  • Pretorius E. The role of platelet and fibrin ultrastructure inidentifying disease patterns. Pathophysiol Haemost Thromb 2008;36(5):251–8.
  • Shrivastava M, Vivekanandhan S. An insight into ultrastructural and morphological alterations of platelets in neurodegenerative diseases. Ultrastruct Pathol 2011;35(3):110–6.
  • Brooks BR. El Escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the El Escorial “clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 1994; 124:96–107.
  • Chaudhuri KR, Crump S, al-Sarraj S, et al. The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study. J Neurol Sci 1995; 129:11–2.
  • Li M, Ona VO, Guegan C, et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000;288:335–9.
  • Petit PX, Susin SA, Zamzami N, et al. Mitochondria and programmed cell death: back to the future. FEBS Lett 1996; 396(1):7–13.
  • Khan SM, Cassarino DS, Abramova NN, et al. Alzheimer's disease cybrids replicate betaamyloid abnormalities through cell death pathways. Ann Neurol 2000; 48:148–55.
  • Cardoso SM, Santana I, Swerdlow RH, Oliveira CR. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J Neurochem 2004;89:1417–26.
  • García ML, Fernández A, Solas MT. Mitochondria, motor neurons and aging. J Neurol Sci 2013;330(1–2):18–26.
  • Trimmer PA, Swerdlow RH, Parks JK, et al. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol 2000;162:37–50.
  • Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40(4):663–71.
  • Esteves AR, Domingues AF, Ferreira IL, et al. Mitochondrial function in Parkinson's disease cybrids containing an NT2 neuron-like nuclear background. Mitochondrion 2008; 8(3):219–28.
  • Scudiero DA, Shoemaker RH, Paull KD, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988; 48(17):4827–33.
  • Stevens MG, Olsen SC. Comparative analysis of using MTT and XTT in colorimetric assays for quantitating bovine neutrophil bactericidal activity. J Immunol Methods 1993;157(1–2):225–31.
  • Puissant A, Grosso S, Jacquel A, et al. Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol. FASEB J 2008; 22(6):1894–904.
  • Nargi FE, Yang TJ. Optimization of the L-M cell bioassay for quantitating tumor necrosis factor alpha in serum and plasma. J Immunol Methods 1993; 159(1–2):81–91.
  • Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 1991; 142(2):257–65.
  • Meshulam T, Levitz SM, Christin L, Diamond RD. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). J Infect Dis 1995;172(4):1153–6.
  • Jost LM, Kirkwood JM, Whiteside TL. Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J Immunol Methods 1992; 147(2):153–65.
  • Yrjanheikki J, Tikka T, Keinanen R, et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999;96:13496–500.
  • Esteves AR, Arduíno DM, Swerdlow RH, et al. Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson's disease cybrids. Antioxid Redox Signal 2009;11(3):439–48.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.